Company Description
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. It provides blood glucose home testing test strips and exciting new concepts for blood testing monitors. The company diagnostics also provides smart phone based electronic medical record ap...
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. It provides blood glucose home testing test strips and exciting new concepts for blood testing monitors. The company diagnostics also provides smart phone based electronic medical record applications which allow physicians to carry access and update their patients' histories, medication data and best care guidelines at the point of care. Decision Diagnostics was founded on July 6, 2000 and is headquartered in Los Angeles, CA.
Valuation
Price to Sales Ratio
2.42
Price to Book Ratio
11.32
Enterprise Value to EBITDA
-1.23
Enterprise Value to Sales
1.39
Total Debt to Enterprise Value
0.41
Efficiency
Receivables Turnover
1.99
Total Asset Turnover
0.36
Liquidity
Current Ratio
0.33
Quick Ratio
0.30
Cash Ratio
0.11
Profitability
Gross Margin
10.02
Operating Margin
-122.06
Pretax Margin
-1,498.91
Net Margin
-1,499.05
Return on Assets
-533.45
Return on Equity
-8,065.67
Return on Total Capital
-71.14
Return on Invested Capital
-8,065.67
Capital Structure
Total Debt to Total Equity
517.67
Total Debt to Total Capital
83.79
Total Debt to Total Assets
51.00
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Mr. Keith M. Berman | 64 | 2003 | Chief Financial Officer, Secretary & Director |
| Mr. Robert Jagunich | 71 | 2003 | Director |
Insider Actions
MarketWatch News on DECN
-
CEO charged in alleged COVID-19 fraud scheme
- Claudia Assis
Other News on DECN
-
4 Companies That Stand To Benefit From Lower Healthcare Prices
- Seeking Alpha
-
Blood Glucose Self-Monitoring Market Not As Bright As It Seems
- Seeking Alpha
-
Decision Diagnostics Takes Victory In Major Case Ruling
- Seeking Alpha
-
Decision Diagnostics Could Be The New Vringo
- Seeking Alpha
-
3 Ways to Trade Diabetes Treatment
- InvestorPlace.com
